These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 21167241

  • 21. CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies.
    Harro J.
    Amino Acids; 2006 Oct; 31(3):215-30. PubMed ID: 16738800
    [Abstract] [Full Text] [Related]

  • 22. Conformationally readdressed CCK-B/delta-opioid peptide ligands.
    Nikiforovich GV, Kolodziej SA, Nock B, Bernad N, Martinez J, Marshall GR.
    Biopolymers; 1995 Oct; 36(4):439-52. PubMed ID: 7578939
    [Abstract] [Full Text] [Related]

  • 23. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
    Blommaert AG, Dhôtel H, Ducos B, Durieux C, Goudreau N, Bado A, Garbay C, Roques BP.
    J Med Chem; 1997 Feb 28; 40(5):647-58. PubMed ID: 9057851
    [Abstract] [Full Text] [Related]

  • 24. Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptors.
    Cappelli A, Anzini M, Vomero S, Menziani MC, De Benedetti PG, Sbacchi M, Clarke GD, Mennuni L.
    J Med Chem; 1996 Feb 16; 39(4):860-72. PubMed ID: 8632410
    [Abstract] [Full Text] [Related]

  • 25. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
    Behr TM, Béhé M, Angerstein C, Gratz S, Mach R, Hagemann L, Jenner N, Stiehler M, Frank-Raue K, Raue F, Becker W.
    Clin Cancer Res; 1999 Oct 16; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Role of cholecystokinin in appetite control and body weight regulation.
    Little TJ, Horowitz M, Feinle-Bisset C.
    Obes Rev; 2005 Nov 16; 6(4):297-306. PubMed ID: 16246215
    [Abstract] [Full Text] [Related]

  • 28. Integrated actions of cholecystokinin on the gastrointestinal tract: use of the cholecystokinin bioassay.
    Liddle RA.
    Gastroenterol Clin North Am; 1989 Dec 16; 18(4):735-56. PubMed ID: 2482253
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pharmacology of CCKRs and SAR studies of peptidic analog ligands.
    Noble F.
    Curr Top Med Chem; 2007 Dec 16; 7(12):1173-9. PubMed ID: 17584139
    [Abstract] [Full Text] [Related]

  • 33. Therapeutic and chemical developments of cholecystokinin receptor ligands.
    de Tullio P, Delarge J, Pirotte B.
    Expert Opin Investig Drugs; 2000 Jan 16; 9(1):129-46. PubMed ID: 11060666
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor.
    Cawston EE, Miller LJ.
    Br J Pharmacol; 2010 Mar 16; 159(5):1009-21. PubMed ID: 19922535
    [Abstract] [Full Text] [Related]

  • 36. CCK in anxiety and cognitive processes.
    Daugé V, Léna I.
    Neurosci Biobehav Rev; 1998 Oct 16; 22(6):815-25. PubMed ID: 9809313
    [Abstract] [Full Text] [Related]

  • 37. Molecular mechanism-based network-like similarity graphs reveal relationships between different types of receptor ligands and structural changes that determine agonistic, inverse-agonistic, and antagonistic effects.
    Iyer P, Stumpfe D, Bajorath J.
    J Chem Inf Model; 2011 Jun 27; 51(6):1281-6. PubMed ID: 21548655
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Moleular models for cholecystokinin-A receptor.
    Dawson ES, Henne RM, Miller LJ, Lybrand TP.
    Pharmacol Toxicol; 2002 Dec 27; 91(6):290-6. PubMed ID: 12688371
    [Abstract] [Full Text] [Related]

  • 40. Screening of soy and milk protein hydrolysates for their ability to activate the CCK1 receptor.
    Staljanssens D, Van Camp J, Billiet A, De Meyer T, Al Shukor N, De Vos WH, Smagghe G.
    Peptides; 2012 Mar 27; 34(1):226-31. PubMed ID: 22138720
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.